CONDORELLI, Gianluigi
 Distribuzione geografica
Continente #
NA - Nord America 8.080
EU - Europa 1.454
AS - Asia 376
AF - Africa 241
SA - Sud America 11
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 5
Totale 10.173
Nazione #
US - Stati Uniti d'America 8.043
FI - Finlandia 415
IE - Irlanda 339
CN - Cina 252
NG - Nigeria 240
DE - Germania 148
FR - Francia 121
IT - Italia 109
SE - Svezia 91
NL - Olanda 83
IN - India 63
GB - Regno Unito 51
BE - Belgio 35
CA - Canada 33
RU - Federazione Russa 33
IL - Israele 18
TR - Turchia 11
SG - Singapore 10
JP - Giappone 7
UA - Ucraina 6
AR - Argentina 5
GR - Grecia 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AU - Australia 4
RO - Romania 4
CL - Cile 3
CU - Cuba 3
PE - Perù 3
TH - Thailandia 3
TW - Taiwan 3
DK - Danimarca 2
IR - Iran 2
KR - Corea 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
PL - Polonia 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
BG - Bulgaria 1
CH - Svizzera 1
EG - Egitto 1
ES - Italia 1
EU - Europa 1
HK - Hong Kong 1
ID - Indonesia 1
IM - Isola di Man 1
LI - Liechtenstein 1
MY - Malesia 1
NO - Norvegia 1
PA - Panama 1
PH - Filippine 1
RS - Serbia 1
Totale 10.173
Città #
Chandler 1.715
Wilmington 1.487
San Mateo 550
Ann Arbor 473
Helsinki 415
Dublin 338
Boardman 326
New York 312
Leawood 248
Lawrence 241
Princeton 241
Benin City 240
Shanghai 233
Ashburn 141
Woodbridge 133
Fairfield 126
Paris 118
Amsterdam 79
Pune 58
San Diego 50
London 47
Seattle 42
Los Angeles 41
Brussels 35
Milan 35
Norwalk 29
Toronto 28
Moscow 25
Falls Church 24
Abbiategrasso 21
Falkenstein 19
Phoenix 14
Houston 11
Kocaeli 11
Des Moines 9
Monmouth Junction 8
Redmond 8
Singapore 8
Rome 7
Tappahannock 6
Hanover 5
Ottawa 5
St Louis 5
Wuhan 5
Dronten 4
Hangzhou 4
Pradleves 4
Augsburg 3
Bangkok 3
Clearwater 3
Havana 3
Lima 3
Novokuznetsk 3
Redwood City 3
Washington 3
Andover 2
Auckland 2
Chicago 2
Chisinau 2
Copenhagen 2
Eden Prairie 2
Ferrara 2
Henderson 2
La Plata 2
Lübeck 2
Milwaukee 2
Naples 2
Quilmes 2
Saint Paul 2
Sale Marasino 2
Taipei 2
Turin 2
Yuncheng 2
Alexandria 1
Bandon 1
Beijing 1
Belgrade 1
Berlin 1
Birmingham 1
Bologna 1
Bolton 1
Brest 1
Brisbane 1
Buenos Aires 1
Cairo 1
Canton 1
Central District 1
Como 1
Delhi 1
Douglas 1
Dundee 1
Friday Harbor 1
Gladstone 1
Goose Creek 1
Izhevsk 1
Jacksonville 1
Jakarta 1
Kuala Lumpur 1
Lenno 1
Makati City 1
Totale 8.071
Nome #
T cell costimulation blockade blunts pressure overload-induced heart failure 64
Circulating biomarkers and cardiac function over 3 years after chemotherapy with anthracyclines: the ICOS-ONE trial 62
Interleukin-6 Trans-Signaling and Risk of Future Cardiovascular Events: A New Avenue for Atheroprotection? 61
The B subunit of the CAAT-binding factor NFY binds the central segment of the co-activator p300 61
Monotherapy with a P2Y12 inhibitor or aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and meta-analysis. 59
Uses and compositions comprising mirnas 58
Endoplasmic reticulum stress at the crossroads of progeria and atherosclerosis 56
Early detection of elevated cardiac biomarkers to optimise risk stratification in patients with COVID-19 56
Endovascular treatment vs. intravenous thrombolysis alone for ischaemic stroke: a meta-analysis of randomised controlled trials 55
Electroactive polyurethane/siloxane derived from castor oil as a versatile cardiac patch, part II: HL-1 cytocompatibility and electrical characterizations 55
Dual Antiplatelet Therapy Continuation Beyond 1 Year After Drug-Eluting Stents: A Meta-Analysis of Randomized Trials 55
Direct oral anticoagulants in addition to antiplatelet therapy for secondary prevention after acute coronary syndromes: an updated systematic review and meta-analysis 55
Continuation versus discontinuation of ACE inhibitors or angiotensin II receptor blockers in COVID-19: Effects on blood pressure control and mortality 55
DNA hydroxymethylation controls cardiomyocyte gene expression in development and hypertrophy 54
Aerobic interval training enhances cardiomyocyte contractility and Ca2+ cycling by phosphorylation of CaMKII and Thr-17 phospholamban 54
MicroRNAs and cardiac pathology 54
Genetic variants in CCNB1 associated with differential gene transcription and risk of coronary in-stent restenosis 54
Dr. John Ross Jr. 54
Inhibition of Class I Histone Deacetylase with an Apicidine Derivative Prevents Cardiac Hypertrophy and Failure 54
Adenovirus-mediated gene transfer of the retinoblastoma family member p130/RB2 blocks restenosis after endothelial injury 54
Adenoviral gene transfer of Akt enhances myocardial contractility and intracellular calcium handling 54
Coral Reef Aorta: A Rare Occlusive Disease of the Aorta Complicating Decision Making for Severe Aortic Stenosis Treatment. 54
The emerging role of microRNAs in cardiovascular biology 53
Mutated p21/WAF/CIP transgene overstatement reduces smooth muscle cell proliferation, macrophage deposition, oxidation-sensitive mechanisms, and restenosis in hypercholesterolemic apolipoprotein E knockout mice 53
Radial Versus Femoral Access for Coronary Interventions Across the Entire Spectrum of Patients With Coronary Artery Disease: A Meta-Analysis of Randomized Trials 52
UHRF1 epigenetically orchestrates smooth muscle cell plasticity in arterial disease 52
Molecular determinants of the physiological adaptation to stress in the cardiomyocyte: a focus on AKT 51
Critical Organizational Issues for Cardiologists in the COVID-19 Outbreak: A Frontline Experience From Milan, Italy 51
Activation of cAMP-PKA signalling in vivo inhibits smooth muscle cell proliferation after vascular injury 51
Chemerin processing in the myocardium: A mechanism in search of a function 50
Therapeutic use of microRNAs in myocardial diseases 50
Akt mediates the cross-talk between beta-adrenergic and insulin receptors in neonatal cardiomyocytes 49
p300/CBP modulates co-operation between MEF2A and TR/RxR 49
The possible role of chromosome X variability in hypertensive familiarity. 49
Akt1 gene transfer to the endothelium corrects impaired endothelial dependent vasorelaxation in hypertensive rats 48
Physiological myocardial hypertrophy: how and why? 48
Epigenetic modifications and noncoding RNAs in cardiac hypertrophy and failure 48
ATP6V0A1 polymorphism and microRNA-637: A pathogenetic role for microRNAs in essential hypertension at last? 48
A G613A missense in the Hutchinson's progeria lamin A/C gene causes a lone, autosomal dominant atrioventricular block. 48
Inhalation Therapy Delivers Nanoparticle-Based Therapeutic Biomolecules To The Diseased Heart 48
Effects of Akt on cardiac myocytes: location counts 47
Deciphering the beta-adrenergic response in human embryonic stem cell-derived-cardiac myocytes: closer to clinical use? 47
Differential expression and functional role of GATA-2, NF-E2 and GATA-1 in normal adult erythropoiesis 47
Prolonged duration of myocardial ischemia in patients with coronary artery disease and impaires cardiopulmonary baroreceptor sensitivity 47
The earliest iodination site of thyroglobulin is residue number 5. The Journal of Biological Chemistry 47
Association of FOXO3A locus with extreme longevity in the Southern Italian Centenarian Study 47
MicroRNAs as Companion Biomarkers for the Diagnosis and Prognosis of Acute Coronary Syndromes 47
Adeno-associated virus-mediated CASQ2 delivery rescues phenotypic alterations in a patient-specific model of recessive catecholaminergic polymorphic ventricular tachycardia 47
Hypoglycemia and hyperglycemia are risk factors for falls in the hospital population 47
Human stem cells for heart failure treatment ready for prime time? 46
Arterial remodeling and atherosclerosis: miRNAs involvement 46
Activation or inactivation of cardiac Akt/mTOR signaling diverges physiological from pathological hypertrophy 46
SOCS1 gene transfer accelerates the transition to heart failure through the inhibition of the gp130/JAK/STAT pathway 46
Genome-wide analysis of histone marks identifying an epigenetic signature of promoters and enhancers underlying cardiac hypertrophy 46
Histone Methyltransferase G9a Is Required for Cardiomyocyte Homeostasis and Hypertrophy. 46
Antiphosphotyrosine recovery of an isulin-stimulated receptor phosphatase activity in FRTL5 cells 45
Exercise training reverses myocardial dysfunction induced by CaMKIIδC overexpression by restoring Ca2+ homeostasis. 45
A Nitric Oxide-releasing Derivative of Enalapril, NCX-899, Prevents Progressive LV Dysfunction and Improves Remodeling in Cardiomyopathic Hamsters with Heart Failure 45
[Continuity of care in heart failure: pilot study of the Tuscany region]. 45
ST-Elevation Myocardial Infarction in Patients with COVID-19: Clinical and Angiographic Outcomes 45
Abnormal responses to saline load in hypertensive patients with parental history of cardiovascular accidents 45
Defining circulating mononuclear cells in heart failure through single-cell RNA sequencing: new insights for an old disease 45
Clinical relevance of clonal hematopoiesis in persons aged ≥80 years 45
Circulating levels of cytokines and their site of production in patients with mild to severe chronic heart failure 44
Immersion before dry simulated dive reduces cardiomyocyte function and increases mortality after decompression 44
Evidence for oxidative activation of c-Myc-dependent nuclear signaling in human coronary SMC and in early lesions of WHHL rabbits: protective effects of vitamin E 44
Translating cardioprotection for patient benefit : position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology 44
CaMKII inhibition rectifies arrhythmic phenotype in a patient-specific model of catecholaminergic polymorphic ventricular tachycardia 44
Deregulation of microRNA-503 contributes to diabetes mellitus-induced impairment of endothelial function and reparative angiogenesis after limb ischemia 44
Cardiotoxic effects, or lack thereof, of anti-ErbB2 immunoagents 44
A pentamer transcriptional complex including tal-1 and retinoblastoma protein downmodulates c-kit expression in normal erythroblasts 44
Akt increases sarcoplasmic reticulum Ca2+ cycling by direct phosphorylation of phospholamban at Thr17 44
MicroRNA and cardiac pathologies 43
mTOR regulates brain morphogenesis by mediating GSK3 signaling. 43
RBP and microRNA control of endothelial cell function 43
Routine assessment of on-clopidogrel platelet reactivity and gene polymorphisms in predicting clinical outcome following drug-eluting stent implantation in patients with stable coronary artery disease 43
Circ_Lrp6, a Circular RNA Enriched in Vascular Smooth Muscle Cells, Acts as a Sponge Regulating miRNA-145 Function 43
MiR-143/145 deficiency attenuates the progression of atherosclerosis in Ldlr-/- mice 43
MicroRNAs and cardiac conduction 43
The cdc2-related kinase, PISSLRE, is essential for cell growth and acts in G2 phase of the cell cycle 42
Epigenetics : a new mechanism of regulation of heart failure? 42
Platelets, endothelium, and circulating microRNA-126 as a prognostic biomarker in cardiovascular diseases : per aspirin ad astra 42
Circular RNAs and heart failure: new players for an old disease 42
miR-128-3p is a novel regulator of vascular smooth muscle cell phenotypic switch and vascular diseases 42
Regulation of cell size and contractile function by AKT in cardiomyocytes 42
MicroRNA-133 controls vascular smooth muscle cell phenotypic switch in vitro and vascular remodeling in vivo 42
Assessment of the 9p21.3 locus in severity of coronary artery disease in the presence and absence of type 2 diabetes 42
Stem cells for cardiomyocyte regeneration: state of the art 41
microRNA MicroRNAs Control Gene Expression: Importance for Cardiac Development and Pathophysiology 41
Developmental regulation of Rb in normal adult erythropoiesis: peak expression and functional role in advanced erythroid differentiation. 92: 41
Stem cells for cardiac repair: state of the art 41
The synergistic role of E1A-binding proteins and tissue-specific transcription factors in differentiation 41
Heart failure: Targeting transcriptional and post-transcriptional control mechanisms of hypertrophy for treatment 41
Fatty acid percentage in erythrocyte membranes of atrial flutter/fibrillation patients and controls 41
MicroRNA-199a-3p and MicroRNA-199a-5p Take Part to a Redundant Network of Regulation of the NOS (NO Synthase)/NO Pathway in the Endothelium. 41
Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice 41
Circulating miR-29a, among other up-regulated microRNAs, is the only biomarker for both hypertrophy and fibrosis in patients with hypertrophic cardiomyopathy 41
Adult c-kit(pos) cardiac stem cells are necessary and sufficient for functional cardiac regeneration and repair 41
Atrial fibrillation and microRNAs 41
TGFβ triggers miR-143/145 transfer from smooth muscle cells to endothelial cells, thereby modulating vessel stabilization 41
Totale 4.761
Categoria #
all - tutte 71.854
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.854


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205 0 0 0 0 0 0 0 0 0 0 0 5
2020/20212.644 21 28 19 9 25 832 348 195 541 355 11 260
2021/20221.206 31 20 20 315 20 18 42 201 102 91 245 101
2022/20234.485 544 116 346 553 500 398 4 419 839 394 300 72
2023/20242.005 213 245 550 147 78 368 144 151 43 66 0 0
Totale 10.345